Your session is about to expire
← Back to Search
Wait List Control for Domestic Violence
Study Summary
This trial looks at two programs designed to help Indigenous mothers and children affected by intimate partner violence in Canada.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Which individuals are eligible to partake in this experimental study?
"Individuals aged between 6 and 13 years with a history of exposure to domestic violence are eligible for inclusion in this research study. A total of 160 participants will be enrolled in the trial."
Are individuals still eligible to participate in this ongoing research?
"According to the details on clinicaltrials.gov, this medical trial is actively seeking participants. It was initially posted on February 23rd, 2024 and most recently revised on March 13th, 2024."
What is the total number of people involved in this clinical trial?
"Affirmative, the details on clinicaltrials.gov reveal that this trial is actively seeking candidates. The study was initially listed on February 23rd, 2024 and last revised on March 13th, 2024. Researchers aim to recruit a total of 160 participants from a single site."
What is the main objective of this clinical trial?
"This research aims to evaluate the impact of an intervention on child depression over a period of approximately 6-8 months post-treatment. Additional objectives involve assessing child resilience using the Child & Youth Resilience Measure - revised (CYRM-R), measuring maternal social support through the Inventory of Socially Supportive Behaviors, and evaluating maternal self-esteem with the Rosenberg Self-Esteem Scale."
Is the study open to individuals who are older than 75 years of age?
"Participants aged between 6 and 13 years old are eligible for enrolment in this clinical trial based on the inclusion criteria."
Share this study with friends
Copy Link
Messenger